Non-coding RNA therapeutics in cardiovascular disease and risk factors: Systematic review

• Main Authors: Meity Ardiana, Meity, Asiyah Nurul Fadila, -, Zakirah Zuhra, -, Nabilla Merdika Kusuma, -, Made Edgard Surya Erlangga Rurus, -, Delvac Oceandy, -
• Format: Article PeerReviewed
• Language: English; English; Indonesian; English
• Published: Elsevier 2023
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/128444/1/20.%20Non-coding%20RNA%20therapeutics.pdf; https://repository.unair.ac.id/128444/3/20.%20Non-coding%20RNA%20therapeutics-1-48.pdf; https://repository.unair.ac.id/128444/11/18.%20karil.pdf; https://repository.unair.ac.id/128444/12/18.%20korespondensi.pdf; https://repository.unair.ac.id/128444/; https://www.sciencedirect.com/science/article/pii/S2468054023000367?via%3Dihub; https://doi.org/10.1016/j.ncrna.2023.06.002
• Institution: Universitas Airlangga

Abstract At present, RNA-based therapy which includes therapies using non-coding RNAs (ncRNAs), antisense oligonucleotides (ASOs), and aptamers are gaining widespread attention as possible ways to target genes in various cardiovascular diseases (CVDs), thereby serving as a promising therapeutic app...